Ongoing Clinical Trials

Advanced Breast Cancer

BriaCell is conducting a Phase 3 clinical trial of Bria-IMT™, BriaCell’s lead candidate, in combination with an immune checkpoint inhibitor. The combination study is listed on ClinicalTrials.gov as NCT06072612.